Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors

Neurobiology of Aging

Volumn 35, Issue 1, 2014, Pages 72-78

  de Jong, Laura W ^a   Forsberg, Lars E ^b   Vidal, Jean Sébastien ^c,d   Sigurdsson, Sigurdur ^e   Zijdenbos, Alex P ^f   Garcia, Melissa ^g   Eiriksdottir, Gudny ^e   Gudnason, Vilmundur ^e   van Buchem, Mark A ^a   Launer, Lenore J ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Service de Gerontologie   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e ICELANDIC HEART ASSOCIATION   (Iceland)

^f INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^g NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Atrophy; Basal ganglia; Hippocampus; Medial temporal lobe; Thalamus; Vascular risk factor

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ARTICLE; AUTOMATION; BASAL GANGLION; BRAIN ATROPHY; BRAIN BLOOD VESSEL; BRAIN PERFUSION; BRAIN SIZE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; MALE; MEDIAL TEMPORAL LOBE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TEMPORAL LOBE;

AGING; ATROPHY; BASAL GANGLIA; HIPPOCAMPUS; MEDIAL TEMPORAL LOBE; THALAMUS; VASCULAR RISK FACTOR;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; ATROPHY; BASAL GANGLIA; BLOOD PRESSURE; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES; RISK FACTORS; TEMPORAL LOBE;

EID: 84885186603     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.07.009     Document Type: Article

References (41)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. fourth ed.
2. Barnes J., Bartlett J.W., van de Pol L.A., Loy C.T., Scahill R.I., Frost C., Thompson P., Fox N.C. Ameta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol. Aging 2009, 30:1711-1723.
3. Cho Z.H., Kang C.K., Han J.Y., Kim S.H., Kim K.N., Hong S.M., Park C.W., Kim Y.B. Observation of the lenticulostriate arteries in the human brain invivo using 7.0T MR angiography. Stroke 2008, 39:1604-1606.
4. Coffey C.E., Lucke J.F., Saxton J.A., Ratcliff G., Unitas L.J., Billig B., Bryan R.N. Sex differences in brain aging: a quantitative magnetic resonance imaging study. Arch. Neurol. 1998, 55:169-179.
5. Debette S., Seshadri S., Beiser A., Au R., Himali J.J., Palumbo C., Wolf P.A., DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011, 77:461-468.
6. de Jong L.W., van der Hiele K., Veer I.M., Houwing J.J., Westendorp R.G., Bollen E.L., de Bruin P.W., Middelkoop H.A., van Buchem M.A., van der Grond J. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008, 131:3277-3285.
7. de Jong L.W., Wang Y., White L.R., Yu B., van Buchem M.A., Launer L.J. Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study. Neurobiol. Aging 2009, 33:424.e1-424.e10.
8. den Heijer T., Launer L.J., Prins N.D., van Dijk E.J., Vermeer S.E., Hofman A., Koudstaal P.J., Breteler M.M. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology 2005, 64:263-267.
9. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., Breteler M.M. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002, 59:746-748.
10. Di Paola M., Caltagirone C., Fadda L., Sabatini U., Serra L., Carlesimo G.A. Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 2008, 18:719-728.
11. Driscoll I., Beydoun M.A., An Y., Davatzikos C., Ferrucci L., Zonderman A.B., Resnick S.M. Midlife obesity and trajectories of brain volume changes in older adults. Hum. Brain Mapp. 2012, 33:2204-2210.
12. Duvernoy H.M. The Human Hippocampus: Functional Anatomy, Vascularization, and Serial Sections With MRI 2005, Springer-Verlag Berlin Heidelberg.
13. Eiriksdottir G., Aspelund T., Bjarnadottir K., Olafsdottir E., Gudnason V., Launer L.J., Harris T.B. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study. Atherosclerosis 2006, 186:222-224.
14. Gattringer T., Enzinger C., Ropele S., Gorani F., Petrovic K.E., Schmidt R., Fazekas F. Vascular risk factors, white matter hyperintensities and hippocampal volume in normal elderly individuals. Dement. Geriatr. Cogn. Disord. 2012, 33:29-34.
15. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., Kitzmiller J., Knowler W.C., Lebovitz H., Lernmark A., Nathan D., Palmer J., Rizza R., Saudek C., Shaw J., Steffes M., Stern M., Tuomilehto J., Zimmet P. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
16. Gouw A.A., Seewann A., van der Flier W.M., Barkhof F., Rozemuller A.M., Scheltens P., Geurts J.J. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J.Neurol. Neurosurg. Psychiatry 2011, 82:126-135.
17. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 25:2735-2752. American Heart Association, National Heart, Lung, and Blood InstituteNational Heart, Lung, and Blood Institute.
18. Harris T.B., Launer L.J., Eiriksdottir G., Kjartansson O., Jonsson P.V., Sigurdsson G., Thorgeirsson G., Aspelund T., Garcia M.E., Cotch M.F., Hoffman H.J., Gudnason V. Age, gene/environment susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am. J. Epidemiol. 2007, 165:1076-1087.
19. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001, 322:1447-1451.
20. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kareholt I., Winblad B., Helkala E.L., Tuomilehto J., Soininen H., Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 2005, 62:1556-1560.
21. Korf E.S., Scheltens P., Barkhof F., de Leeuw F.E. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?. Dement. Geriatr. Cogn. Disord. 2005, 20:331-337.
22. Korf E.S., White L.R., Scheltens P., Launer L.J. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 2004, 44:29-34.
23. Korf E.S., White L.R., Scheltens P., Launer L.J. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 2006, 29:2268-2274.
24. Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 2013, 9:106-118.
25. Lu P.H., Thompson P.M., Leow A., Lee G.J., Lee A., Yanovsky I., Parikshak N., Khoo T., Wu S., Geschwind D., Bartzokis G. Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J.Alzheimers Dis. 2011, 23:433-442.
26. Mahley R.W., Rall S.C. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 2000, 1:507-537.
27. Mitchell G.F., Vita J.A., Larson M.G., Parise H., Keyes M.J., Warner E., Vasan R.S., Levy D., Benjamin E.J. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study. Circulation 2005, 112:3722-3728.
28. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 2000, 55:134-136.
29. Nunnemann S., Wohlschlager A.M., Ilg R., Gaser C., Etgen T., Conrad B., Zimmer C., Muhlau M. Accelerated aging of the putamen in men but not in women. Neurobiol. Aging 2009, 30:147-151.
30. Prins N.D., van Dijk E.J., den Heijer T., Vermeer S.E., Jolles J., Koudstaal P.J., Hofman A., Breteler M.M. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005, 128:2034-2041.
31. Qiu C., von Strauss E., Winblad B., Fratiglioni L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 2004, 35:1810-1815.
32. Schmahmann J.D. Vascular syndromes of the thalamus. Stroke 2003, 34:2264-2278.
33. Sigurdsson S., Aspelund T., Forsberg L., Fredriksson J., Kjartansson O., Oskarsdottir B., Jonsson P.V., Eiriksdottir G., Harris T.B., Zijdenbos A., van Buchem M.A., Launer L.J., Gudnason V. Brain tissue volumes in the general population of the elderly: the AGES-Reykjavik study. Neuroimage 2012, 59:3862-3870.
34. Smallwood A., Oulhaj A., Joachim C., Christie S., Sloan C., Smith A.D., Esiri M. Cerebral subcortical small vessel disease and its relation to cognition in elderly subjects: a pathological study in the Oxford Project to Investigate Memory and Ageing (OPTIMA) cohort. Neuropathol. Appl. Neurobiol. 2012, 38:337-343.
35. Sveinbjornsdottir S., Sigurdsson S., Aspelund T., Kjartansson O., Eiriksdottir G., Valtysdottir B., Lopez O.L., van Buchem M.A., Jonsson P.V., Gudnason V., Launer L.J. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J.Neurol. Neurosurg. Psychiatry 2008, 79:1002-1006.
36. Tolppanen A.M., Solomon A., Soininen H., Kivipelto M. Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J.Alzheimers Dis. 2012, 32:531-540.
37. Vermeer S.E., Longstreth W.T., Koudstaal P.J. Silent brain infarcts: a systematic review. Lancet Neurol. 2007, 6:611-619.
38. Vidoni E.D., Townley R.A., Honea R.A., Burns J.M. Alzheimer disease biomarkers are associated with body mass index. Neurology 2011, 77:1913-1920.
39. Waldstein S.R., Lefkowitz D.M., Siegel E.L., Rosenberger W.F., Spencer R.J., Tankard C.F., Manukyan Z., Gerber E.J., Katzel L. Reduced cerebral blood flow in older men with higher levels of blood pressure. J.Hypertens. 2010, 28:993-998.
40. Zhu Y.C., Dufouil C., Soumare A., Mazoyer B., Chabriat H., Tzourio C. High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. J.Alzheimers Dis. 2010, 22:663-672.
41. Zhu Y.C., Tzourio C., Soumare A., Mazoyer B., Dufouil C., Chabriat H. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke 2010, 41:2483-2490.